Group 1 - The core point of the article highlights the recent trading activity of southbound funds in relation to Jinxin Reproductive Medicine (01951.HK), indicating a reduction of 626,000 shares on February 27, while there were two days of net increases totaling 4.5723 million shares over the last five trading days [1] - Over the past 20 trading days, Jinxin Reproductive Medicine experienced net increases in southbound funds for 12 days, accumulating a total of 9.4858 million shares [1] - As of now, southbound funds hold 1.463 billion shares of Jinxin Reproductive Medicine, representing 53.03% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [1] - The company's services are mainly provided in China and the United States [1]
锦欣生殖（01951.HK）：2月27日南向资金减持62.6万股